Provided by Tiger Fintech (Singapore) Pte. Ltd.

HANSOH PHARMA

33.950
+0.9002.72%
Volume:4.42M
Turnover:149.55M
Market Cap:201.90B
PE:42.13
High:34.300
Open:33.100
Low:33.100
Close:33.050
Loading ...

Hansoh Pharmaceutical Group Stock Sheds 1.0% in Hong Kong

Dow Jones
·
Yesterday

Hansoh Pharmaceutical Group Stock Rises 2.5% in Hong Kong

Dow Jones
·
15 Jul

Hansoh Pharmaceutical Group Stock Rallies 3.5% in Hong Kong

Dow Jones
·
14 Jul

Hansoh Pharmaceutical Group Stock Slips 1.3% in Hong Kong

Dow Jones
·
11 Jul

Hansoh Pharmaceutical Group Stock Slips 1.1% in Hong Kong

Dow Jones
·
08 Jul

A Look At The Intrinsic Value Of Hansoh Pharmaceutical Group Company Limited (HKG:3692)

Simply Wall St.
·
06 Jul

Hansoh Pharmaceutical Group Stock Climbs 2.5% in Hong Kong

Dow Jones
·
04 Jul

LIVE MARKETS-Chinese biotech licensing deals draw U.S. interest despite modest size, Macquarie says

Reuters
·
04 Jul

Chinese Biotech Companies' Outlicensing Trend Will Likely Be Sustainable -- Market Talk

Dow Jones
·
03 Jul

Hansoh Pharmaceutical Group Stock Rises 1.7% in Hong Kong

Dow Jones
·
02 Jul

Hansoh Pharmaceutical Group Stock Advances 2.2% in Hong Kong

Dow Jones
·
30 Jun

Moon Inc. Issues Profit Warning, Expects 90% Decline in Annual Profit Due to Reduced Demand and Increased Competition

Reuters
·
25 Jun

Hansoh Pharmaceutical Group Co. Ltd. Conducted Annual General Meeting

Reuters
·
20 Jun

Moon Inc. Announces Upcoming Board Meeting to Approve Annual Results and Consider Dividend

Reuters
·
18 Jun

US Pharma Bets Big on China to Snap up Potential Blockbuster Drugs

Reuters
·
17 Jun

Moon Inc. Announces Key Management Changes: New CFO, Company Secretary, and Chief Investment Officer Appointed

Reuters
·
11 Jun

Chinese Pharmaceutical Firms Likely Outperformed on Strengthened Innovative Pipeline -- Market Talk

Dow Jones
·
10 Jun

Hansoh Pharmaceutical's Earnings Set to Benefit From New Drug Approvals -- Market Talk

Dow Jones
·
09 Jun

Hansoh Pharma's Aumolertinib Receives UK MHRA Approval for NSCLC Treatment, Marking First Overseas Launch of China-Developed EGFR-TKI

Reuters
·
05 Jun

BUZZ-Hansoh hits near 4-year peak as its cancer drug gets UK marketing approval

Reuters
·
04 Jun